Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial

BACKGROUND: Prader-Willi syndrome (PWS) is a rare complex genetic disorder and is characterized by short stature, muscular hypotonia, abnormal body composition, psychomotor retardation, and hyperphagia. Recombinant human growth hormone (rhGH) treatment improves the symptoms in children with PWS, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Aram, Choi, Jin-Ho, Sohn, Young Bae, Eom, Yunae, Lee, Jiyoon, Yoo, Han-Wook, Jin, Dong-Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739953/
https://www.ncbi.nlm.nih.gov/pubmed/31511031
http://dx.doi.org/10.1186/s13023-019-1195-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739953/
https://www.ncbi.nlm.nih.gov/pubmed/31511031
http://dx.doi.org/10.1186/s13023-019-1195-1

Ejemplares similares